EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

A pretreatment ECM-high/immune-low transcriptomic score is associated with pathological complete response after neoadjuvant therapy in breast cancer

Tao Wang iD, Xiaoyun Wu

PLOS One · 05.11.2026 · 21 (11) · e0357532

DOI: 10.1371/journal.pone.0357532 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift PLOS One, online erschienen am 05.11.2026. Verfasst von Tao Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid and Breast Surgery, Hubei No. 3 People's Hospital of Jianghan University, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Breast Neoplasms, Transcriptome, Extracellular Matrix. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this retrospective public-cohort observational study, we evaluated a biologically motivated extracellular matrix (ECM)-high/immune-low transcriptomic score for association with pathological complete response (pCR) after neoadjuvant therapy in breast cancer. The score contrasted standardized ECM/fibroblast and immune-response components. Cohort-specific logistic models adjusted for available clinical covariates; their performance was evaluated separately and was not validation of a locked transported model. In I-SPY2/GSE194040 (n = 987; 319 pCR events), a one-standard-deviation higher score was associated with lower pCR odds (odds ratio [OR] 0.687, 95% confidence interval [CI] 0.588–0.803). Inverse adjusted estimates were also observed in GSE25066 (OR 0.744, 95% CI 0.568–0.975) and GSE20271 (OR 0.407, 95% CI 0.232–0.715). Apparent areas under the receiver operating characteristic curve (AUCs) for these multivariable models were 0.750, 0.732 and 0.798; corresponding 500-bootstrap optimism-corrected estimates were 0.731, 0.713 and 0.765, conditional on processed scores. GSE20194 estimates were nonsignificant, and substantial record overlap with GSE25066 prevented interpretation as additional independent confirmation. A GSE25066 sensitivity restricted to deposited human epidermal growth factor receptor 2 (HER2)-negative status retained direction but had a confidence interval crossing unity. Higher scores correlated with lower immune-related reverse-phase protein array signals in matched I-SPY2 samples. The findings support a hypothesis-generating bulk-transcriptomic response association, with limited cross-cohort robustness. Heterogeneous treatment, sampling, assay and endpoint annotations, together with absent spatial and prospective validation, preclude claims of causality or clinical treatment-selection utility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoadjuvant TherapyBreast NeoplasmsTranscriptomeExtracellular MatrixHumansFemalePathologic Complete ResponseRetrospective StudiesROC CurveMiddle AgedGene Expression Profiling

Autor:innen und Institutionen

  • Department of Thyroid and Breast Surgery, Hubei No. 3 People's Hospital of Jianghan University, Wuhan, Hubei, China.
  • Department of Cardiothoracic, Thyroid and Breast Surgery, Enshi Central Hospital, Enshi, Hubei, China.

ORCID-Profile: Tao Wang

Zitieren

APA

Wang, T., & Wu, X. (2026). A pretreatment ECM-high/immune-low transcriptomic score is associated with pathological complete response after neoadjuvant therapy in breast cancer. PLOS One, 21(11), e0357532. https://doi.org/10.1371/journal.pone.0357532

Vancouver

Wang T, Wu X. A pretreatment ECM-high/immune-low transcriptomic score is associated with pathological complete response after neoadjuvant therapy in breast cancer. PLOS One. 2026;21(11):e0357532. doi:10.1371/journal.pone.0357532

BibTeX
@article{Wang2026,
  author = {Wang, Tao and Wu, Xiaoyun},
  title = {A pretreatment ECM-high/immune-low transcriptomic score is associated with pathological complete response after neoadjuvant therapy in breast cancer},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {11},
  pages = {e0357532},
  doi = {10.1371/journal.pone.0357532}
}
Kostenlos starten →